“The INCA Trial: A Multicenter, Randomized, Phase II, Open-Label Clinical Trial to Evaluate the Combination Therapy With Ipilimumab Plus Nivolumab Versus Chemotherapy (Pemetrexate-Cisplatin) in Patients With Advanced Non-Squamous NSCLC Naive to Treatment”. Principles and Practice of Clinical Research, vol. 4, no. 1, July 2018, pp. 6-13, https://journal.ppcr.org/index.php/ppcrjournal/article/view/62.